These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15922693)

  • 1. Evaluation of cases of severe statin-related transaminitis within a large health maintenance organization.
    Charles EC; Olson KL; Sandhoff BG; McClure DL; Merenich JA
    Am J Med; 2005 Jun; 118(6):618-24. PubMed ID: 15922693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low myopathy rates associated with statins as monotherapy or combination therapy with interacting drugs in a group model health maintenance organization.
    Shanahan RL; Kerzee JA; Sandhoff BG; Carroll NM; Merenich JA
    Pharmacotherapy; 2005 Mar; 25(3):345-51. PubMed ID: 15843281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors related to adherence to statin therapy.
    McGinnis B; Olson KL; Magid D; Bayliss E; Korner EJ; Brand DW; Steiner JF
    Ann Pharmacother; 2007 Nov; 41(11):1805-11. PubMed ID: 17925498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term persistence with statin treatment in a not-for-profit health maintenance organization: a population-based retrospective cohort study in Israel.
    Chodick G; Shalev V; Gerber Y; Heymann AD; Silber H; Simah V; Kokia E
    Clin Ther; 2008 Nov; 30(11):2167-79. PubMed ID: 19108805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients.
    Nichols GA; Koro CE
    Clin Ther; 2007 Aug; 29(8):1761-70. PubMed ID: 17919557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring statin safety in primary care.
    Tragni E; Filippi A; Mazzaglia G; Sessa E; Cricelli C; Catapano AL
    Pharmacoepidemiol Drug Saf; 2007 Jun; 16(6):652-7. PubMed ID: 17300133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compliance with a statin treatment in a usual-care setting: retrospective database analysis over 3 years after treatment initiation in health maintenance organization enrollees with dyslipidemia.
    Caspard H; Chan AK; Walker AM
    Clin Ther; 2005 Oct; 27(10):1639-46. PubMed ID: 16330301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does statin therapy decrease the risk for bleeding in patients who are receiving warfarin?
    Douketis JD; Melo M; Bell CM; Mamdani MM
    Am J Med; 2007 Apr; 120(4):369.e9-369.e14. PubMed ID: 17398234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of statin therapy on allergic patients with asthma.
    Ostroukhova M; Kouides RW; Friedman E
    Ann Allergy Asthma Immunol; 2009 Dec; 103(6):463-8. PubMed ID: 20084838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction in mortality associated with statin therapy in patients with severe sepsis.
    Dobesh PP; Klepser DG; McGuire TR; Morgan CW; Olsen KM
    Pharmacotherapy; 2009 Jun; 29(6):621-30. PubMed ID: 19476415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin-associated adverse cognitive effects: survey results from 171 patients.
    Evans MA; Golomb BA
    Pharmacotherapy; 2009 Jul; 29(7):800-11. PubMed ID: 19558254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes in 45 patients with statin-associated myopathy.
    Hansen KE; Hildebrand JP; Ferguson EE; Stein JH
    Arch Intern Med; 2005 Dec 12-26; 165(22):2671-6. PubMed ID: 16344427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diplopia, blepharoptosis, and ophthalmoplegia and 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitor use.
    Fraunfelder FW; Richards AB
    Ophthalmology; 2008 Dec; 115(12):2282-5. PubMed ID: 18930555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for statin-associated rhabdomyolysis.
    Schech S; Graham D; Staffa J; Andrade SE; La Grenade L; Burgess M; Blough D; Stergachis A; Chan KA; Platt R; Shatin D
    Pharmacoepidemiol Drug Saf; 2007 Mar; 16(3):352-8. PubMed ID: 16892458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of statin use on muscle strength, cognition, and depressive symptoms in older adults.
    Agostini JV; Tinetti ME; Han L; McAvay G; Foody JM; Concato J
    J Am Geriatr Soc; 2007 Mar; 55(3):420-5. PubMed ID: 17341246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marked elevation of liver transaminases after high-dose fluvastatin unmasks chronic hepatitis C: safety and re-challenge.
    Chen YW; Lai HW; Wang TD
    Acta Neurol Taiwan; 2007 Sep; 16(3):163-7. PubMed ID: 17966956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of statin hepatotoxicity in patients with hepatitis C.
    Khorashadi S; Hasson NK; Cheung RC
    Clin Gastroenterol Hepatol; 2006 Jul; 4(7):902-7; quiz 806. PubMed ID: 16697272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of direct-to-consumer advertising of hydroxymethylglutaryl coenzyme a reductase inhibitors on attainment of LDL-C goals.
    Bradford WD; Kleit AN; Nietert PJ; Ornstein S
    Clin Ther; 2006 Dec; 28(12):2105-18; discussion 2104. PubMed ID: 17296467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tendinous disorders attributed to statins: a study on ninety-six spontaneous reports in the period 1990-2005 and review of the literature.
    Marie I; Delafenêtre H; Massy N; Thuillez C; Noblet C;
    Arthritis Rheum; 2008 Mar; 59(3):367-72. PubMed ID: 18311771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of statin use with a pathologic complete response to neoadjuvant chemoradiation for rectal cancer.
    Katz MS; Minsky BD; Saltz LB; Riedel E; Chessin DB; Guillem JG
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1363-70. PubMed ID: 16029794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.